X-154428729-G-C

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001183.6(ATP6AP1):​c.37G>C​(p.Gly13Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,147,658 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000035 ( 0 hom., 0 hem., cov: 25)
Exomes 𝑓: 0.000032 ( 0 hom. 11 hem. )

Consequence

ATP6AP1
NM_001183.6 missense

Scores

2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.452

Publications

0 publications found
Variant links:
Genes affected
ATP6AP1 (HGNC:868): (ATPase H+ transporting accessory protein 1) This gene encodes a component of a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. Vacuolar ATPase (V-ATPase) is comprised of a cytosolic V1 (site of the ATP catalytic site) and a transmembrane V0 domain. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, and receptor-mediated endocytosis. The encoded protein of this gene may assist in the V-ATPase-mediated acidification of neuroendocrine secretory granules. This protein may also play a role in early development. [provided by RefSeq, Aug 2013]
ATP6AP1-DT (HGNC:25138): (ATP6AP1 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.090290904).
BP6
Variant X-154428729-G-C is Benign according to our data. Variant chrX-154428729-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1961380.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS2
High Hemizygotes in GnomAdExome4 at 11 XL,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP6AP1NM_001183.6 linkc.37G>C p.Gly13Arg missense_variant Exon 1 of 10 ENST00000369762.7 NP_001174.2
ATP6AP1-DTNR_103768.1 linkn.-250C>G upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP6AP1ENST00000369762.7 linkc.37G>C p.Gly13Arg missense_variant Exon 1 of 10 1 NM_001183.6 ENSP00000358777.2 Q15904

Frequencies

GnomAD3 genomes
AF:
0.0000352
AC:
4
AN:
113527
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000749
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000357
AC:
3
AN:
83970
AF XY:
0.0000379
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000567
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000643
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000319
AC:
33
AN:
1034131
Hom.:
0
Cov.:
30
AF XY:
0.0000328
AC XY:
11
AN XY:
335499
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22483
American (AMR)
AF:
0.0000373
AC:
1
AN:
26789
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25213
South Asian (SAS)
AF:
0.00
AC:
0
AN:
49114
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
30052
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3964
European-Non Finnish (NFE)
AF:
0.0000393
AC:
32
AN:
814644
Other (OTH)
AF:
0.00
AC:
0
AN:
43764
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.423
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000352
AC:
4
AN:
113527
Hom.:
0
Cov.:
25
AF XY:
0.00
AC XY:
0
AN XY:
35665
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31320
American (AMR)
AF:
0.00
AC:
0
AN:
10884
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2661
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3583
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2870
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6355
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.0000749
AC:
4
AN:
53393
Other (OTH)
AF:
0.00
AC:
0
AN:
1537
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.538
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jan 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 13 of the ATP6AP1 protein (p.Gly13Arg). This variant is present in population databases (no rsID available, gnomAD 0.007%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with ATP6AP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1961380). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Benign:1
Aug 28, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
14
DANN
Benign
0.95
DEOGEN2
Benign
0.044
T;T;T
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.48
T;T;T
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.090
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.76
N;.;.
PhyloP100
0.45
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-0.49
N;N;N
REVEL
Benign
0.067
Sift
Benign
0.20
T;T;T
Sift4G
Benign
0.87
T;T;T
Polyphen
0.0010
B;.;.
Vest4
0.23
MutPred
0.50
Gain of disorder (P = 0.0169);Gain of disorder (P = 0.0169);Gain of disorder (P = 0.0169);
MVP
0.17
MPC
0.33
ClinPred
0.027
T
GERP RS
-1.1
PromoterAI
0.018
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Varity_R
0.063
gMVP
0.33
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs992965475; hg19: chrX-153657075; API